ArticleCureus2026
Massive Warfarin-Induced Lingual Hematoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin K antagonist (VKA) therapy can cause major bleeding, most commonly GI or intracranial. Airway hematomas, though rare, are potentially life-threatening. Spontaneous lingual hematoma is an exceptionally uncommon presentation, insidious in onset and potentially rapidly fatal if overlooked. We report an elderly woman on warfarin for atrial fibrillation (AF) who developed progressive tongue swelling, dysphonia, and dyspnea over 24 hours, without trauma, a dental procedure, or fever. Examination revealed cervical and lingual swelling with gingival bleeding. Despite a clinically threatened airway, she was managed conservatively with emergent reversal using four-factor prothrombin complex concentrate and IV vitamin K, with close monitoring. Warfarin was switched to apixaban, with full recovery on follow-up. This case highlights a rare bleeding site associated with warfarin therapy, with only nine cases reported to date, and underscores the challenge of anticoagulant selection in frail, high-risk elderly patients, in whom bleeding and thrombotic risks must be individually balanced.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.